Pricing
  1. US-listed companies
  2. FILANA THERAPEUTICS, INC.
  3. Financials
  4. Return on equity (%)

FILANA THERAPEUTICS, INC.【FLNA】

Market cap
$106.76M
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Dec 31, 2024-17.2-67.73%
Dec 31, 2023-53.3+68.20%
Dec 31, 2022-31.7+69.27%
Dec 31, 2021-18.7+68.86%
Dec 31, 2020-11.1-50.09%
Dec 31, 2019-22.2-50.36%
Dec 31, 2018-44.7-46.81%
Dec 31, 2017-84.1+35.88%
Dec 31, 2016-61.9+51.83%
Dec 31, 2015-40.7+45.33%
Dec 31, 2014-28-127.31%
Dec 31, 2013102.7-957.18%
Dec 31, 2012-12

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)